ACHL   $1.05  0.0 Market Closed

Achilles Therapeutics PLC
Total Cash 95.11M
totalCashPerShare 2.315
EBITDA -65.90M
Total Debt 4.46M
quickRatio 7.937
currentRatio 8.242
Total Revenue
debtToEquity 3.865
Revenue/Share
ROA -0.26819
ROE -0.44219002
grossProfits
freeCashflow -30.14M
operatingCashflow -48.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -48.12M
forwardPE -0.5588235
floatShares 20.83M
sharesOutstanding 41.09M
sharesShort 212.55K
sharesShortPriorMonth 3.85K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.62%
Short Ratio help_outline 0.12%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.81
Price To Book help_outline 0.37
earningsQuarterlyGrowth
netIncomeToCommon -63.97M
trailingEps -1.59%
forwardEps -1.87%
enterpriseToEbitda 0.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 28
lastUpdated Nov. 7, 2024, 4:59 a.m.